Author

Anna Chang

Observed name: ANNA CHANG

OpenAlex ID: A5028122117

149-OR: Evaluation of the Next Generation 180-Day Long-Term Implantable Eversense CGM System: PROMISE Study

2021 · SATISH K. GARG, DAVID R. LILJENQUIST, et al. · Diabetes · 2

Abstract #300 Evaluation of the Accuracy of an Implantable CGM System with an Updated Glucose Calculation Algorithm

2019 · Mark Christiansen, Timothy Bailey, et al. · Endocrine Practice · 1

A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Acmopatide (CT-868), a Fully Biased GLP-1/GIP Receptor Agonist, in Adults With Type 1 Diabetes and Overweight or Obesity

2026 · Klara R. Klein, Jeremy Pettus, et al. · Diabetes Care

Works count: 3

Citation count: 3

H-index: 1

I10-index: